Catalyst Crew Technologies Corp. announced a comprehensive leadership transition with Dr. Kevin Rodan Levy assuming multiple executive roles including Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer, and Sole Director. This appointment, effective February 17, 2026, follows the resignation of the company's prior officers and directors as previously disclosed in regulatory filings. The leadership change represents a significant step in the company's strategic repositioning toward artificial intelligence-enabled healthcare technology solutions.
Dr. Rodan brings a unique combination of clinical medical training, healthcare operations experience, and technology platform leadership to his new role. Since 2021, he has served as Chief Executive Officer of Grupo Casamed 18 C.A., where he focused on healthcare delivery management and organizational development. His background also includes leadership of EmpleUp, a technology-focused human capital and recruitment platform. This professional experience aligns directly with Catalyst Crew's announced strategic direction toward healthcare technology solutions.
The company's transition toward AI-enabled healthcare technology comes at a time when emerging markets face significant challenges in healthcare access and efficiency. Dr. Rodan emphasized the company's focus on developing scalable platforms specifically designed to address these challenges. "Our focus is on disciplined execution of the Company's strategic transition into AI-enabled healthcare solutions, with particular emphasis on scalable platforms that address access and efficiency challenges in emerging markets," stated Dr. Rodan. The company's initial emphasis will be on Latin American markets, where healthcare modernization represents both a significant need and opportunity.
Catalyst Crew Technologies Corp. intends to pursue opportunities across several key healthcare technology areas including telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. The company's approach involves building an integrated healthcare technology platform through technology development initiatives, strategic partnerships, and targeted acquisitions. This comprehensive strategy aims to position the company to address growing demand for modernized healthcare delivery systems in regions with developing healthcare infrastructure.
The company will continue providing updates through regulatory filings with the U.S. Securities and Exchange Commission and other appropriate public disclosures. Additional information about the company's strategic direction and initiatives is available through its official website. The leadership transition represents a critical inflection point for the company as it moves from planning to execution phase of its healthcare technology strategy. The appointment of an executive with both healthcare operations and technology platform experience suggests the company is positioning itself to bridge the gap between clinical needs and technological solutions in emerging healthcare markets.
